1. Home
  2. BWA vs AXSM Comparison

BWA vs AXSM Comparison

Compare BWA & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BorgWarner Inc.

BWA

BorgWarner Inc.

HOLD

Current Price

$52.89

Market Cap

10.9B

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$168.23

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWA
AXSM
Founded
1987
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
9.0B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
BWA
AXSM
Price
$52.89
$168.23
Analyst Decision
Buy
Strong Buy
Analyst Count
16
17
Target Price
$57.81
$210.65
AVG Volume (30 Days)
2.2M
483.4K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
1.29%
N/A
EPS Growth
N/A
38.56
EPS
1.28
N/A
Revenue
$14,316,000,000.00
N/A
Revenue This Year
$1.64
$58.18
Revenue Next Year
$3.53
$55.45
P/E Ratio
$41.21
N/A
Revenue Growth
1.63
N/A
52 Week Low
$24.40
$86.99
52 Week High
$70.08
$191.50

Technical Indicators

Market Signals
Indicator
BWA
AXSM
Relative Strength Index (RSI) 46.63 54.48
Support Level $41.16 $151.26
Resistance Level $56.65 $169.11
Average True Range (ATR) 1.46 5.41
MACD 0.04 1.92
Stochastic Oscillator 31.66 72.02

Price Performance

Historical Comparison
BWA
AXSM

About BWA BorgWarner Inc.

BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2024, 23% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: